MetaCap

EUDA Health Holdings Limited Class A (EUDA)

NASDAQ: EUDAHealth CareMedical/Nursing ServicesUSD

15.96-1.33 (-7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EUDA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$47.79M
EPS (TTM)
-$1.18
52-week range
5.26 – 68.00
Day range
15.96 – 17.99
Volume / Avg
36.51K / 37.77K
Beta
—

52-week range

$5.26$68.00

EUDA stock today

EUDA Health (EUDA) closed at $15.96 on Nov 20, down 7.69% (-$1.33), versus the S&P 500's 3.70% decline. Shares are 76.5% below their 52-week high of $68.00, set on Nov 28, 2025 and 203.4% above the 52-week low of $5.26, near the bottom of the past year's range. EUDA is down 65.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 71.8%.

EUDA Health has posted a net loss over the last twelve months (EPS of -$1.18), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About EUDA Health

Company profile

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services.

Industry
Medical/Nursing Services
CEO
Mr. Alfred Lim
Headquarters
Singapore
Employees
123
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, EUDA Health generated $6.8 million in revenue, up 70.0% from fiscal 2024, its 2nd consecutive year of revenue growth. EUDA Health reported a net loss of $2.8 million, compared with a loss of $15.4 million a year earlier. Gross margin was 43.9% (up from 19.0%) and operating margin -36.3%.

EUDA Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2022
Revenue$6.82M$4.01M$3.71M$3.76M—
Growth+70.04%+8.22%-1.54%——
Net income$-2.77M$-15.36M$-10.04M$-24.88M$-1.76M
EPS (diluted)$-1.48$-9.46$-8.77$-2.07—

Analyst forecast

Forecast

Consensus

none

Avg. price target

$55.00+244.61%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Q1 2022)
Dec 22, 2021
EPS actual vs est.
$-0.02 vs —

EUDA news

All EUDA news

EUDA Health peers

Health Care sector
EUDA peer companies
CompanyPrice% ChgMarket capCompare
AIRSAirSculpt Technologies Inc.0.5907-9.72%$43.67Mvs EUDA
ALPSALPS Group Inc1.15-3.36%$36.43Mvs EUDA
NAKANakamoto Inc.3.44-15.89%$63.11Mvs EUDA
LFMDLifeMD Inc.1.45-9.40%$69.84Mvs EUDA
DCGODocGo Inc.0.175+1.98%$17.32Mvs EUDA
CCMConcord Medical Services Holdings Limited ADR3.55-1.11%$15.41Mvs EUDA
BMGLBasel Medical Group Ltd0.3832+20.01%$5.20Mvs EUDA
ATPCAgape ATP Corporation1.16-15.94%$1.16Mvs EUDA

Indexes, lists and sector

EUDA Health stock FAQ

What is EUDA Health's stock price today?

EUDA last traded at $15.96 as of Nov 20, 4:00 PM EST, down 7.69% on the day. Prices are delayed at least 15 minutes.

Does EUDA Health pay a dividend?

No. EUDA Health does not currently pay a regular cash dividend.

Who is EUDA Health's CEO?

Mr. Alfred Lim is the chief executive officer of EUDA Health Holdings Limited Class A, which has about 123 employees.

Has EUDA ever split its stock?

Yes. The most recent EUDA stock split was a 1-for-20 split on Mar 23, 2026.

What is the EUDA 52-week high?

The 52-week high for EUDA is $68.00 and the 52-week low is $5.26. The stock is currently 76.5% below its high.

Compare EUDA